Effective Brain Targeting Using the Self-Emulsifying Drug Delivery Systems

Area of Science:

• Nanotechnology and Pharmaceutical Sciences
• Neuroscience and Drug Delivery

Background:

• The blood-brain barrier (BBB) significantly restricts the delivery of neurotherapeutics to the central nervous system.
• Self-emulsifying drug delivery systems (SEDDS) represent a promising nanocarrier approach to overcome BBB limitations for lipophilic drugs.

Purpose of the Study:

• To review the formulation, mechanisms, and translational potential of SEDDS for enhancing neurotherapeutic delivery across the BBB.
• To explore advancements in SEDDS, including ligand-functionalized and AI-optimized systems, for improved brain drug targeting.

Main Methods:

• Comprehensive literature review of SEDDS formulation principles, excipient selection, and BBB transport mechanisms.
• Evaluation of oral and intranasal SEDDS, innovative SEDDS modifications (ligand-functionalized, hybrid, mucoadhesive).
• Discussion of AI/ML tools for formulation design, PBPK modeling, and comparative analysis with experimental data.

Main Results:

• SEDDS demonstrate potential for improving solubility, permeability, and targeted delivery of lipophilic neurotherapeutics.
• AI/ML and PBPK modeling offer advanced tools for optimizing SEDDS preformulation and predicting pharmacokinetic behavior.
• Preclinical data, patent landscape, and innovation trajectories suggest growing clinical readiness for SEDDS.

Conclusions:

• SEDDS are a viable strategy for overcoming BBB challenges in neurotherapeutics, with ongoing innovations enhancing their potential.
• Addressing challenges in excipient safety, scale-up, and regulatory compliance is crucial for successful clinical translation.
• Future research should focus on optimizing SEDDS formulations and leveraging advanced modeling for efficient neurotherapeutic delivery.